|
000
| 02404nam 2200421zi 4500 |
|---|
| 001 | 9.913119 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107182724 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 220707e20220714onc ob f000 0 eng d |
|---|
| 020 | |a9780660444543|q(report) |
|---|
| 020 | |a9780660444550|q(summary) |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP5-139/1-2022E-PDF |
|---|
| 086 | 1 |aHP5-139/2-2022E-PDF |
|---|
| 245 | 00|aRecommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. |
|---|
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cJuly 14, 2022. |
|---|
| 264 | 4|c©2022 |
|---|
| 300 | |a1 online resource (27 pages) + |esummary (6 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Recommandations sur l'utilisation du vaccin Spikevax de Moderna contre la COVID-19 chez les enfants de 6 mois à 5 ans. |
|---|
| 500 | |aAt head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 25-27). |
|---|
| 650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada. |
|---|
| 650 | 0|aVaccination of children|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tRecommandations sur l'utilisation du vaccin Spikevax de Moderna contre la COVID-19 chez les enfants de 6 mois à 5 ans.|w(CaOODSP)9.913120 |
|---|
| 856 | 40|qPDF|s678 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP5-139-1-2022-eng.pdf|z(report) |
|---|
| 856 | 40|qPDF|s419 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP5-139-2-2022-eng.pdf|z(summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years.html|z(report) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years/summary-july-14-2022.html|z(summary) |
|---|